Exploring your options for Inflammatory Myopathies in India? Ginger Healthcare brings together a carefully chosen panel of reputed rheumatologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Inflammatory Myopathies. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Here are the most reputed hospitals in India for Inflammatory Myopathies. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Inflammatory myopathies are a group of rare autoimmune conditions in which the immune system mistakenly attacks the body's own muscle tissue, causing progressive muscle weakness, fatigue, and sometimes involvement of the skin, lungs, and other organs. The umbrella term covers several distinct subtypes — including dermatomyositis, polymyositis, immune-mediated necrotising myopathy (IMNM), antisynthetase syndrome, inclusion body myositis (IBM), and juvenile dermatomyositis — each with a different pattern of involvement, response to treatment, and long-term outlook. Management is long-term and led by a rheumatologist, often working alongside neurologists, pulmonologists, and physical therapists. For most subtypes, treatment centres on suppressing the abnormal immune response with corticosteroids and steroid-sparing immunosuppressants, while inclusion body myositis is managed primarily through physical and swallowing therapy rather than drug treatment. With appropriate management, most patients achieve meaningful improvement in strength, function, and quality of life.
Long-term oral medication combining high-dose steroids (tapered over months) with a second agent such as methotrexate, azathioprine, or mycophenolate to suppress the immune attack on muscles.
Estimated cost: ~$300 – $500
Typical tests: Creatine kinase (CK), LDH, aldolase, CBC with differential, Liver function tests (LFT) and kidney function tests (KFT), Fasting blood glucose and HbA1c, Myositis-specific antibody panel (anti-Jo-1, anti-Mi-2, anti-MDA5, anti-SRP, anti-HMGCR, ANA), ESR and CRP, Pulmonary function test (spirometry and DLCO), High-resolution CT chest (if lung involvement suspected). Done in India before admission.
Estimated cost in India: $1,500 – $3,000
Treatment duration in India: ~3 weeks (~5 hospital visit days across the full span)
A course of intravenous antibody infusions given over several days, used when standard oral medications have not adequately controlled weakness or when swallowing muscles are severely affected.
Estimated cost: ~$300 – $500
Typical tests: Creatine kinase (CK), LDH, aldolase, CBC with differential, Liver function tests (LFT) and kidney function tests (KFT), Serum IgA level (mandatory before IVIG — IgA deficiency risk), Myositis-specific antibody panel, ESR and CRP, Fasting blood glucose, High-resolution CT chest (if lung involvement suspected). Done in India before admission.
Estimated cost in India: $3,000 – $6,000
Treatment duration in India: ~5 weeks (~10 hospital visit days across the full span)
Rituximab is an intravenous biologic that depletes B-cells to dampen the autoimmune response, used in patients with antisynthetase syndrome, IMNM, or severe dermatomyositis not responding to standard immunosuppressants.
Estimated cost: ~$300 – $500
Typical tests: Creatine kinase (CK), LDH, aldolase, CBC with differential, Liver function tests (LFT) and kidney function tests (KFT), Hepatitis B surface antigen and hepatitis B core antibody (mandatory before rituximab), Hepatitis C antibody, Myositis-specific antibody panel, Chest X-ray or high-resolution CT chest, Quantiferon TB Gold or Mantoux test (TB screening before immunosuppression). Done in India before admission.
Estimated cost in India: $4,000 – $8,000
Treatment duration in India: ~3 weeks (~5 hospital visit days across the full span)
A structured, supervised programme of graded exercise, strength training, and occupational therapy — the cornerstone of care for inclusion body myositis and an essential adjunct to medication in all other subtypes.
Estimated cost: ~$200 – $300
Typical tests: Creatine kinase (CK) and LDH (baseline muscle enzyme level), CBC and metabolic panel (baseline fitness assessment), Manual muscle strength testing (clinical assessment, no lab cost), Pulmonary function test (if respiratory muscle involvement suspected), Swallowing assessment / videofluoroscopy (if dysphagia present). Done in India before admission.
Estimated cost in India: $1,500 – $3,000
Treatment duration in India: ~3 weeks (~15 hospital visit days across the full span)
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
